Air entrapment causing early inappropriate shocks in a patient with a subcutaneous cardioverter-defibrillator

Air entrapment causing early inappropriate shocks in a patient with a subcutaneous cardioverter-defibrillator

Bibliographic Details
Main Authors:	Sing-Chien Yap, MD, PhD, Rohit E. Bhagwandien, MD, Tamas Szili-Torok, MD, PhD, Dominic A.M.J. Theuns, PhD
Format:	Article
Language:	English
Published:	Elsevier 2015-05-01
Series:	HeartRhythm Case Reports
Subjects:	Inappropriate shocks Implantable cardioverter-defibrillator Brugada syndrome Subcutaneous air Oversensing
Online Access:	http://www.sciencedirect.com/science/article/pii/S221402711500038X

Similar Items

A novel screening test for inappropriate shocks due to myopotentials from the subcutaneous implantable cardioverter–defibrillatorKey Findings
by: Yuji Ishida, MD, PhD, et al.
Published: (2020-04-01)

Importance of exercise testing shortly after subcutaneous implantable cardioverter-defibrillator implantation in patients with Brugada syndrome – The first case of associated inappropriate shock in Japan
by: Kohei Ishibashi, MD, PhD, et al.
Published: (2017-04-01)

Inappropriate shocks in a patient with a subcutaneous implantable cardioverter-defibrillator
by: Sana M. Al-Khatib, MD, MHS, FHRS, et al.
Published: (2016-11-01)

T-wave oversensing during drug challenge test after subcutaneous implantable cardioverter-defibrillator implantation in a patient with Brugada syndrome
by: Tsukasa Kamakura, MD, PhD, et al.
Published: (2016-09-01)

Impact of a novel algorithm designed to reduce T-wave oversensing with the subcutaneous defibrillator in a patient with type I Brugada electrocardiogram
by: Serge Boveda, MD, et al.
Published: (2018-01-01)

Oversensing of an unexpected atrial flutter. A new tool to improve detection of supraventricular arrhythmias in subcutaneous implantable cardioverter-defibrillators
by: Luca Santini, MD, PhD, et al.
Published: (2017-06-01)

A case of inappropriate implantable cardioverter defibrillator therapy induced by T-wave oversensing due to hyperkalemia
by: Kosuke Aoki, et al.
Published: (2015-12-01)

Inappropriate implantable cardioverter-defibrillator shocks in Brugada syndrome: Pattern in primary and secondary prevention
by: Aimé Bonny, et al.
Published: (2017-01-01)

OVERSENSING AS A CAUSE OF INAPPROPRIATE IMPLANTABLE CARDIOVERTER- DEFIBRILLATOR THERAPY - CASE REPORT
by: Tomislav Kostić, et al.
Published: (2013-12-01)

Initial experience with the subcutaneous implantable cardioverter-defibrillator in a single Japanese center
by: Nobuhiro Nishii, MD, et al.
Published: (2017-08-01)

SMART pass will prevent inappropriate operation of S‐ICD
by: Motomi Tachibana, et al.
Published: (2019-02-01)

Changing place, changing future: Repositioning a subcutaneous implantable cardioverter-defibrillator can resolve inappropriate shocks secondary to myopotential oversensing
by: Paola Berne, MD, et al.
Published: (2017-10-01)

A novel cause of inappropriate subcutaneous implantable cardioverter-defibrillator therapies after a generator change
by: Timothy M. Markman, MD, et al.
Published: (2021-08-01)

Repeat inappropriate defibrillator discharges following defibrillator implantation. What is the mechanism and treatment?
by: Jeremy W. Docekal, MD, et al.
Published: (2016-09-01)

Two cases of inappropriate implantable cardioverter-defibrillator therapies due to T wave oversensing induced by body twisting
by: Nobuhiro Nishii, MD, et al.
Published: (2017-04-01)

Implantable cardioverter-defibrillator programming after first occurrence of ventricular tachycardia in the Multicenter Automatic Defibrillator Implantation Trial–Reduce Inappropriate Therapy (MADIT-RIT)Key Findings
by: Mehmet K. Aktas, MD, MBA, FHRS, et al.
Published: (2020-06-01)

Inappropriate Shock Delivered By Implantable Cardioverter Defibrillator - Cardiac Resynchronization Therapy (ICD-CRT) Due To Myopotential Oversensing
by: Hamid Barakpour, et al.
Published: (2009-01-01)

Ventricular tachycardia detection with the subcutaneous implantable cardioverter-defibrillator: Tracing the cause of an absent tracing
by: Fadi Mansour, MD, et al.
Published: (2020-02-01)

Ventricular tachycardia slower than the rate cut-off of a subcutaneous cardiac defibrillator sensed and successfully treated as a result of oversensing
by: Ali A. Sovari, MD, et al.
Published: (2017-02-01)

Implantable cardioverter-defibrillator oversensing due to electric shock
by: Jurčević Ružica, et al.
Published: (2010-01-01)

T wave oversensing in subcutaneous implantable cardioverter defibrillator secondary to hematoma formation: A potential cause of early postimplantation inappropriate shocks
by: Ahmad Halawa, et al.
Published: (2019-02-01)

Successful intermuscular implantation of subcutaneous implantable cardioverter defibrillator in a Japanese patient with pectus excavatum
by: Yusuke Kondo, M.D., Ph.D., et al.
Published: (2017-02-01)

Patient characteristics and in‐hospital complications of subcutaneous implantable cardioverter‐defibrillator for Brugada syndrome in Japan
by: Iwanari Kawamura, et al.
Published: (2019-12-01)

Inappropriate shocks from a subcutaneous implantable cardioverter-defibrillator due to oversensing during periods of rate-related bundle branch block
by: Maria João Sousa, MD, et al.
Published: (2017-02-01)

Intermuscular pocket for subcutaneous implantable cardioverter defibrillator: Single-center experience
by: Paola Ferrari, MD, et al.
Published: (2016-06-01)

T-wave oversensing during left ventricular pacing causing inappropriate defibrillation
by: Joshua Payne, MD, MPH, et al.
Published: (2017-10-01)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
by: Krishnakumar Nair, et al.
Published: (2014-07-01)

Oversensing of atrial fibrillatory waves in a subcutaneous implantable cardioverter-defibrillator
by: Ankur A. Karnik, MD, FHRS, FACC, et al.
Published: (2017-04-01)

Successful management of wound dehiscence after implantation of a subcutaneous implantable cardioverter-defibrillator without device removal
by: Mitsuhiro Fukata, MD, PhD, et al.
Published: (2017-09-01)

Usefulness of lead repositioning from left to right sternal border for a patient with subcutaneous implantable cardioverter defibrillator showing high defibrillation threshold
by: Yasushi Wakabayashi, et al.
Published: (2019-02-01)

Quality of Life and Psychological Factors in Patients with Implantable Cardioverter Defibrillator
by: Akiko Suyama-Chishaki, MD PhD, et al.
Published: (2007-01-01)

Anxiety and depression in inherited channelopathy patients with implantable cardioverter-defibrillators
by: Sajya M. Singh, BS, et al.
Published: (2021-08-01)

Risk factors for the first and second inappropriate implantable cardioverter-defibrillator therapy
by: Nobuhiro Nishii, et al.
Published: (2021-06-01)

Inappropriate subcutaneous implantable cardioverter-defibrillator therapy due to R-wave amplitude variation: Another challenge in device management
by: Syeda A. Batul, MD, et al.
Published: (2017-01-01)

High Incidence of Inappropriate Alarms in Patients with Wearable Cardioverter-Defibrillators: Findings from the Swiss WCD Registry
by: Boldizsar Kovacs, et al.
Published: (2021-08-01)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
by: Mohammad-Ali Jazayeri, MD, et al.
Published: (2017-06-01)

The runaway defibrillator…A case of an implantable cardioverter-defibrillator that failed communication and deactivation with a magnet
by: Mahmoud Assaad, MD, et al.
Published: (2016-01-01)

Monitoring zone-associated implantable cardioverter defibrillator shock: A case report
by: Hisayasu Matsuzaki, et al.
Published: (2012-08-01)

Evaluation of subcutaneous implantable cardioverter-defibrillator performance in patients with ion channelopathies from the EFFORTLESS cohort and comparison with a meta-analysis of transvenous ICD outcomes
by: Pier D. Lambiase, MBChB, PhD, FHRS, et al.
Published: (2020-12-01)

First direct human evidence of a probable implantable cardioverter-defibrillator lead-related scar serving as a substrate for ventricular tachycardia
by: Pal Abraham, MD, et al.
Published: (2015-01-01)